IMAI Medtech

IMAI Medtech develops a 3D-histology platform for cancer diagnostics. The Zurich company combines automated tissue processing, imaging and reconstruction to produce fully stained three-dimensional tissue samples and help pathology teams examine tumour structures beyond conventional slices.

Facts

  • Segment: Lab Automation
  • Country: Switzerland
  • Founded: 2024
  • Website: https://www.imai-medtech.com/

Market context

Comparable profiles and adjacent companies connected by shared workflow, capability, or stack position.

  • Medra - comparable profile - peer: Lab Automation Platform Builder
  • Opentrons - comparable profile - peer: Lab Automation Platform Builder
  • Automata - comparable profile - peer: Lab Automation Platform Builder

View market context

Team

  • Robert McGinn - Co-Founder - Co-founded IMAI's automated three-dimensional histology platform.

View team